YD Bio Ltd (YDES) Balance Sheet
YDES balance sheet, 2025
December 31, 2025 · U.S. dollars$13.8M assets = $16.6M liabilities + −$2.9M equity
Liabilities exceed assets: shareholders’ equity is negative (−$2.9M).
Both columns are drawn to the same scale: what YDES owns equals what it owes plus shareholders’ equity. Hover a block for its value.
YDES financial health
Descriptive bands, not a rating. Fiscal 2025.
YDES balance sheet trends, 2020–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $117.6M2020 | $13.8M2025 | −34.9%/yr | |
| Total liabilities | $17.8M2020 | $16.6M2025 | −1.4%/yr | |
| Shareholders’ equity | $99.8M2020 | −$2.9M2025 | — | |
| Cash & short-term investments | $693,8182020 | $6.0M2025 | +54.0%/yr | |
| Total debt | $47,5762023 | $6,7642025 | −62.3%/yr | |
| Net cash (debt) | $39,5222023 | $6.0M2025 | +$6.0M | |
| Working capital | $528,5482020 | $8.0M2025 | +$7.5M | |
| Book value per share | $6.822020 | −$0.042025 | — | |
| Current ratio | 2.752020 | 5.882025 | +3.13 | |
| Debt / equity | 2.072023 | 0.002024 | −2.07 | |
| Shares outstanding | 14.6M2020 | 66.7M2025 | +35.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
YDES assets
YDES liabilities and equity
YDES debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
YDES balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $6.0M | $3.1M | $87,098 | $14,129 | $5,403 | $693,818 |
| Cash & equivalents | $6.0M | $3.1M | $87,098 | $14,129 | $5,403 | $693,818 |
| Receivables | $712,263 | $262,796 | $98,434 | $18,073 | $0 | $0 |
| Inventory | $1.9M | $37,335 | $69,404 | $0 | $0 | $0 |
| Other current assets | $1.1M | $35,453 | $16,788 | $170,503 | $124,157 | $136,949 |
| Total current assets | $9.7M | $3.5M | $271,724 | $202,705 | $129,560 | $830,767 |
| Property, plant & equipment (net) | $67,810 | $88,077 | $14,305 | $0 | $0 | $0 |
| Goodwill & intangible assets | $2.6M | $2.7M | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $10,618 | $0 | $0 | $0 |
| Other non-current assets | $1.4M | $628,232 | $24,565 | $17.7M | $117.9M | $116.8M |
| Total assets | $13.8M | $6.9M | $321,212 | $17.9M | $118.1M | $117.6M |
| Liabilities | ||||||
| Accounts payable | $413,290 | $26,743 | $17,976 | — | — | — |
| Short-term debt | $6,764 | $16,871 | $47,576 | — | — | — |
| Deferred revenue | $30,153 | — | — | — | — | — |
| Total current liabilities | $1.6M | $263,060 | $298,218 | $5.6M | $2.0M | $302,219 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $6,764 | $22,265 | $13,257 | — | — | — |
| Other long-term liabilities | $15.0M | $10,920 | $2.2M | $1.2M | $7.1M | $17.5M |
| Total liabilities | $16.6M | $273,980 | $298,218 | $6.7M | $9.1M | $17.8M |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $7,079 | $144,177 | $105,200 | $17.7M | $115.0M | $115.0M |
| Retained earnings (deficit) | −$10.2M | −$1.9M | −$515,484 | −$6.5M | −$6.5M | −$15.2M |
| Accumulated other comprehensive income | $213,936 | $45,072 | $47,211 | — | — | — |
| Total shareholders' equity | −$2.9M | $6.6M | $22,994 | $11.2M | $109.0M | $99.8M |
| Key figures | ||||||
| Total debt | $6,764 | $22,555 | $47,576 | — | — | — |
| Net cash (debt) | $6.0M | $3.1M | $39,522 | — | — | — |
| Working capital | $8.0M | $3.2M | −$26,494 | −$5.3M | −$1.9M | $528,548 |
| Tangible book value | −$5.5M | $3.9M | $22,994 | $11.2M | $109.0M | $99.8M |
| Book value per share | −$0.04 | — | $0.00 | — | $7.45 | $6.82 |
| Shares outstanding | 66.7M | — | 70.1M | — | 14.6M | 14.6M |
| Current ratio | 5.88 | 13.18 | 0.91 | 0.04 | 0.06 | 2.75 |
| Quick ratio | 4.09 | 12.91 | 0.62 | 0.01 | 0.00 | 2.30 |
| Debt / equity | — | 0.00 | 2.07 | — | — | — |
| Equity / assets | −20.7% | 96.0% | 7.2% | 62.4% | 92.3% | 84.9% |
| Jun '26 | Dec '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $2.7M | $6.0M | $6,312 | $403 | $3.1M | $2 | $39,970 | $4,487 | $4,228 |
| Cash & equivalents | $2.7M | $6.0M | $6,312 | $403 | $3.1M | $2 | $39,970 | $4,487 | $4,228 |
| Receivables | $558,863 | $712,263 | $53,905 | $53,905 | $262,796 | $53,906 | $53,905 | $18,672 | $18,672 |
| Inventory | $1.9M | $1.9M | $373,518 | $0 | $37,335 | $0 | $0 | $0 | $69,404 |
| Other current assets | $478,149 | $1.1M | $0 | $179,319 | $35,453 | $139,156 | $217,428 | $215,050 | $173,841 |
| Total current assets | $5.6M | $9.7M | $192,082 | $233,627 | $3.5M | $193,064 | $311,303 | $238,209 | $266,145 |
| Property, plant & equipment (net) | $57,329 | $67,810 | $83,827 | $0 | $88,077 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $2.5M | $2.6M | $2.9M | $0 | $2.7M | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.9M | $1.4M | $0 | $3.3M | $628,232 | $10.6M | $10.4M | $13.3M | $13.0M |
| Total assets | $10.1M | $13.8M | $3.0M | $3.5M | $6.9M | $10.8M | $10.7M | $13.5M | $13.2M |
| Liabilities | |||||||||
| Accounts payable | $371,594 | $413,290 | $69,925 | — | $26,743 | — | — | — | $17,976 |
| Short-term debt | $5,002 | $6,764 | — | — | $16,871 | — | — | — | — |
| Deferred revenue | $198,593 | $30,153 | — | — | — | — | — | — | — |
| Total current liabilities | $1.1M | $1.6M | $11.2M | $10.8M | $263,060 | $10.1M | $9.9M | $9.2M | $8.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $5,002 | $6,764 | $15,767 | — | — | — | — | — | — |
| Other long-term liabilities | $4.5M | $15.0M | $7.8M | $5.9M | $10,920 | $3.6M | $5.9M | $23.3M | $2.2M |
| Total liabilities | $5.6M | $16.6M | $19.0M | $16.8M | $273,980 | $13.6M | $15.8M | $32.6M | $10.3M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $7,084 | $7,079 | $2.7M | $3.2M | $144,177 | $10.5M | $10.3M | $13.2M | $12.6M |
| Retained earnings (deficit) | −$3.5M | −$10.2M | −$18.7M | −$16.4M | −$1.9M | −$13.3M | −$15.3M | −$32.2M | −$9.7M |
| Accumulated other comprehensive income | $142,317 | $213,936 | — | — | $45,072 | — | — | — | — |
| Total shareholders' equity | $4.5M | −$2.9M | −$16.1M | −$13.2M | $6.6M | −$2.9M | −$5.1M | −$19.0M | $3.0M |
| Key figures | |||||||||
| Total debt | $5,002 | $6,764 | — | — | $22,555 | — | — | — | — |
| Net cash (debt) | $2.7M | $6.0M | — | — | $3.1M | — | — | — | — |
| Working capital | $4.5M | $8.0M | −$11.0M | −$10.6M | $3.2M | −$9.9M | −$9.6M | −$9.0M | −$7.8M |
| Tangible book value | $2.0M | −$5.5M | −$19.0M | −$13.2M | $3.9M | −$2.9M | −$5.1M | −$19.0M | $3.0M |
| Book value per share | $0.06 | −$0.04 | — | — | — | — | — | — | — |
| Shares outstanding | 70.8M | 70.5M | — | — | — | — | — | — | — |
| Current ratio | 5.23 | 5.88 | 0.02 | 0.02 | 13.18 | 0.02 | 0.03 | 0.03 | 0.03 |
| Quick ratio | 3.01 | 4.09 | 0.01 | 0.01 | 12.91 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt / equity | 0.00 | — | — | — | 0.00 | — | — | — | — |
| Equity / assets | 44.5% | −20.7% | −543.8% | −376.7% | 96.0% | −26.6% | −47.3% | −141.0% | 22.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.
YDES financial position
At the end of fiscal 2025 (December 31, 2025), YD Bio had total assets of $13.8 million (up 100.7% from a year earlier), total liabilities of $16.6 million and shareholders' equity of -$2.9 million. It held $6.0 million in cash and short-term investments against $0.0 million of debt, a net cash position of $6.0 million. Its current ratio was 5.88. In the latest quarter (ended June 30, 2026) total assets were $10.1 million and equity $4.5 million.
Related: YDES income statement, YDES cash flow statement, YDES key metrics. See the YDES stock overview for the latest quote and news.
YDES balance sheet FAQ
What are YD Bio's total assets?
YD Bio reported total assets of $13.8 million at the end of fiscal 2025 (December 31, 2025), compared with $6.9 million a year earlier.
How much debt does YD Bio have?
YD Bio had $0.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does YD Bio have?
YD Bio held $6.0 million in cash and short-term investments at the end of fiscal 2025; with $0.0 million of debt that is net cash of $6.0 million.
What is YD Bio's book value?
YD Bio's shareholders' equity (book value) was -$2.9 million at the end of fiscal 2025, or −$0.04 per share.
What is YD Bio's current ratio?
YD Bio had current assets of $9.7 million and current liabilities of $1.6 million, a current ratio of 5.88 (it can cover its short-term obligations).
How much goodwill does YD Bio have?
YD Bio carried $2.6 million of goodwill and intangible assets, 18.9% of total assets, at the end of fiscal 2025.